Start up. Grow up. Succeed.

Nexigen GmbH receives BMBF grant

Nexigen GmbH has been awarded a grant of approximately 1.0 million Euro by the German Federal Ministry of Education and Research (Bundesministerium für Bildung und Forschung – BMBF) under the KMU-Innovation Programme.

December 2014

The funding supports Nexigen in the pre-clinical development of its lead peptide targeting an intracellular component of the Wnt signaling pathway. The continuous support of Nexigen’s lead development program by the BMBF emphasizes Nexigen’s approach to target intracellular “undruggable” disease-relevant proteins playing key roles in cancer stem cells.